Orthopedic Implant Antibacterial Coatings Surface Treatment Market Analysis 2028

Orthopedic Implant Antibacterial Coatings Surface Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Passive Surface Finishing/Modifications (PSM), Active Surface Finishing/Modifications (ASM), PeriOperative Antibacterial Local Carriers or Coatings (LCC)); Material Type (Metallic Coatings and Non-Metallic Coatings), and Geography

  • Report Code : TIPRE00017477
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 148
Buy Now

The orthopedic implant antibacterial coatings surface treatment market is projected to reach US$ 178.55 Million by 2028 from US$ 87.15 Million in 2021; it is estimated to register a CAGR of 10.8% from 2021 to 2028.

Bacterial infection and infection-induced immune responses have become a life-threatening concern Among patients undergoing orthopedic implant surgery. Biocontamination of conventional biomaterials causes bacterial invasion in injured areas, resulting in postoperative illness. As a result, anti-infection and immune-evasive coatings for orthopedic implants are desperately needed. There is an increase in demand for orthopedic implants such as screws, plates, nails, and artificial joints from hospitals for orthopedic surgery. Moreover, there is a rise in demand for coating the implants with an anti-biofouling polymer, which prevents bio substances and bacteria from adhering onto the surface.

  

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Orthopedic Implant Antibacterial Coatings Surface Treatment Market: Strategic Insights

orthopedic-implant-antibacterial-coatings-surface-treatment-market
Market Size Value inUS$ 87.15 Million in 2021
Market Size Value byUS$ 178.55 Million by 2028
Growth rateCAGR of 10.8% from 2021-2028
Forecast Period2021-2028
Base Year2021
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

The orthopedic implant antibacterial coatings surface treatment market is segmented into type, material type, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the market, emphasizing parameters such as market trends, technological advancements, and market dynamics, along with the analysis of the competitive landscape of the globally leading market players.     

Lucrative Regions for Orthopedic Implant Antibacterial Coatings Surface Treatment Market

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Market Insights

Rise in prevalence of implant-associated infections to drive orthopedic implant antibacterial coatings surface treatment market growth

Implant-associated infections result from various factors, including antibacterial prophylaxis, bacterial load, microorganism and host's type, surgical procedure and technique, and type of implant. The increasing prevalence of implant-associated infections is one of the prominent factors driving the orthopedic implant antibacterial coatings surface treatment market.

For instance, as per the study reported by the Journal of Orthopaedic Surgery and Research in 2018, the prevalence of implant-associated infections in orthopedic trauma patients was found to be in the range of 5 to 10%. Each year, 750,000–1,000,000 implant-associated infections cases are found in the US, and the government needs to spend more than US$ 1.6 billion to cover the expense of the excess hospital charges due to implant-associated infections. Especially with the widespread use of orthopedic implants, the number of infected implants was continued to increase. Even if the infected implants can be successfully removed by secondary surgery, the functionality of the limb and the fracture healing may be limited, which may eventually lead to fatal surgical operations such as amputation, joint arthroplasty, or arthrodesis. Therefore, the high epidemiology of implant-associated infections generates the demand for appropriate implant antibacterial coating treatment, which will support the market's growth.

The demand for the orthopedic implant antibacterial coatings surface treatment has been rising because of the heavy incidence of prosthetic joint infection (PJI). PJI is the most serious complication following total joint arthroplasty. According to an article published in Annals of Joint 2021, the estimated cost of treating PJI in the US alone is US$ 1.62 billion. The incidence of PJI varies with the joint involved. According to the study, total knee arthroplasty, total hip arthroplasty, and total shoulder arthroplasty have reported incidences of 0.25% to 2%, 0.5% to 1%, and less than 1%, respectively. Around 23 to 25% of revision total knee arthroplasty procedures and 12 to 15% of total hip arthroplasty procedures are performed for PJI.

Moreover, according to the investor's presentation published by aap Implantate AG, in 2020, in orthopedic trauma, it has been estimated that up to 30% of cases may result in infection. Similarly, fracture-related infection (FRI) is a severe complication after bone injury and can pose a serious diagnostic challenge. According to the Federal Statistical Office of Germany (Destatis), the prevalence of FRI increased by 0.28 from 8.4 cases per 100,000 inhabitants to 10.7 cases per 100,000 inhabitants between 2008 and 2018. Hence, the increasing prevalence of orthopedic implant-associated infections will increase the demand for orthopedic implant antibacterial coatings surface treatment.

Technological Advancements in Antibacterial Coatings Contribute Significantly to Orthopedic Implant Antibacterial Coatings Surface Treatment Market Growth

Microbial colonization, infection, and biofilm formation are significant complications in the use of implants and are the predominant risk factors in implant failure. To reduce implant-related infections, antimicrobial materials are increasingly being investigated and applied to implant surfaces. Antimicrobial coating technology seems to be the most effective way to improve infection control in a hospital setting without compromising patient care. The scope of applications of antibacterial coating is quite high, owing to its functional properties to prevent the growth of microorganisms. Many surface-coating technologies are under investigation, ranging from pharmaceutical excipients and antimicrobial agents for medical devices and surgical implants to coatings that ensure disinfection of implant surfaces. Silver is well known for its antimicrobial and antibacterial properties, so it is widely used in the antimicrobial coating. Nanostructured silver is the most prevalent antimicrobial agent that can be used in the form of nanoparticles, nanowires, and nanolayers for orthopedic implants. Titanium dioxide is also well known for its antimicrobial properties, and the compound has been shown to kill 99.9% of E. coli colonies. Hydrophilic coatings and biofilm-inhibiting surface technology are some of the recent technologies in implantable devices.

The increasing focus of market players in offering technologically advanced medical products and orthopedic implants with antibacterial coating will contribute to market growth during the forecast period. For instance, Specialty Coating Systems Inc. offers new SCS microRESIST Antimicrobial Parylene Technology, which can effectively eliminate harmful microorganisms on coated medical devices. It can coat the medical implant with biocompatible Parylene coatings with effective antimicrobial properties.

Similarly, Germany-based company DOT GmbH offers orthopedic implantable devices physical vapor deposition (PVD) coatings technology. The PVD coating technique involves applying ceramic hard material layers to the implants using a special arc evaporation technique with nitrogen. The implants with this kind of ceramic coating can largely prevent foreign body reactions and significantly improve the biocompatibility of the implant surfaces. In addition to this, DOT has also developed an innovative technology called BONIT, which includes an electrochemical process of applying a thin, resorbable calcium phosphate layer to orthopedic implants. Calcium phosphates are used in medical coating technology because they ensure the rapid growth of bone tissue and promote a connection with high strength between the implant and the surrounding tissue, thereby shortening the healing phase. Hence, such technological advancement in the antimicrobial coating will drive the orthopedic implant antimicrobial coating surface treatment market.

Type Insights               

Based on type, the global orthopedic implant antibacterial coatings surface treatment market is segmented into passive surface finishing/modifications (PSM), active surface finishing/modifications (ASM), and peri-operative antibacterial local carriers or coatings (LCC). In 2020, the active surface finishing/modifications (ASM) segment held the largest share of the market. Furthermore, the same segment is expected to register the highest CAGR in the market during 2021–2028. ASM involves the application of pharmacologically active antibacterial agents or compounds like antibiotics, antiseptics, metal ions, or organic molecules on the surface of orthopedic implants. Such pharmacologically activated coatings on implant surfaces may change the implant from a passive or pharmacologically inert medical device to a drug-loaded medical device. Companies such as DOT GmbH and Harland Medical Systems, Inc. provide antibacterial coatings surface treatment, which is expected to drive the market during the forecast period.   

Material Type Insights

Based on material type, the orthopedic implant antibacterial coatings surface treatment market is segmented into metallic coatings and non-metallic coatings. The metallic coatings segment would hold a larger market share in 2021. Moreover, the same segment is expected to hold a significant market share in the orthopedic implant antibacterial coatings surface treatment market due to the high efficacy at low dosage levels without the development of antimicrobial resistance. Metal-based antimicrobials coating can provide sustainable solutions toward orthopedic implant-associated infections, which is expected to drive the segment.

Orthopedic Implant Antibacterial Coatings Surface Treatment Market, by Type – 2021 and 2028

Orthopedic Implant Antibacterial Coatings Surface Treatment Market, by Type – 2021 and 2028
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Product launches and mergers and acquisitions are highly adopted strategies by the global orthopedic implant antibacterial coatings surface treatment market players. A few of the recent key market developments are listed below:

In September 2021, aap Implantate AG announced that three implants coated with the company's innovative antibacterial silver technology were implanted in patients to check the healing process. aap addressed one of the greatest and inadequately solved challenges in traumatology, i.e., surgical site infections (SSI), as all three surgeries had excellent healing processes, and no indications of infections were recorded. The overall results are a positive indication for the planned human clinical study that aap intended to launch in Germany in the fourth quarter of 2021 to obtain CE approval.


In March 2020, Covalon Technologies Ltd. launched its breakthrough antimicrobial technology called CovaGuard, formulated to kill the COVID-19 virus (or "SARS-CoV-2") and other viruses, bacteria, and pathogens and provide continuous protection by trapping and deactivating microbes over an extended period. CovaGuard can be safely applied on the skin and protective medical equipment.

Health care systems are overburdened due to the COVID-19 pandemic, and the delivery of medical care to all patients has become a challenge worldwide. As the COVID-19 pandemic continues to unfold, medical device companies are finding difficulties in managing their operations. Many companies offering products for orthopedic implant antibacterial coatings surface treatment have their business operations in the US, and their business is adversely being negatively affected by the COVID-19 pandemic. This pandemic has disrupted the product distribution, as well as resulted in temporary closures of company facilities. For instance, as per the British Journal of Surgery published in May 2020, orthopedic procedures were affected the most, with 6.3 million operations canceled worldwide due to the pandemic. Moreover, cancellations of elective surgeries to reduce exposure to COVID-19 in the hospital and operating rooms into intensive care units have hampered the growth of the orthopedic implant antibacterial coatings surface treatment market. However, in 2021 as the new COVID-19 cases are going down the as the situation is recovering thus, the market is expected to grow in upcoming days.

Orthopedic Implant Antibacterial Coatings Surface Treatment – Market Segmentation

The global orthopedic implant antibacterial coatings surface treatment market is segmented into type, material type, and geography. In terms of product, the market is segmented into passive surface finishing/modifications (PSM), active surface finishing/modifications (ASM), and peri-operative antibacterial local carriers or coatings (LCC). Based on material type, the orthopedic implant antibacterial coatings surface treatment market is segmented into metallic coatings and non-metallic coatings. In terms of geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South and Central America.

Company Profiles

  • DOT GmbH
  • Covalon Technologies Ltd.
  • Sciessent LLC
  • Harland Medical Systems, Inc.
  • Isoflux, Inc.
  • Allvivo Vascular, Inc.
  • aap Implantate AG
  • BASF SE
  • Agienic Inc.
  • ARAN BIOMEDICAL
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Type, Material Type, and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


What is orthopedic implant antibacterial coatings surface treatment?

Among patients undergoing orthopedic implant surgery, bacterial infection and infection-induced immune responses have become a life-threatening concern. Biocontamination of conventional biomaterials causes bacterial invasion in injured areas, resulting in postoperative illness. As a result, anti-infection and immune-evasive coatings for orthopedic implants are desperately needed. Orthopedic implants such as screws, plates, nails, and artificial joints have grown in great demand by hospitals for orthopedic surgery. Coating the implants with an anti-biofouling polymer, which prevents bio substances and bacteria from adhering onto the surface, is in demand.

What are the driving factors for the orthopedic implant antibacterial coatings surface treatment market across the globe?

Key factors driving the growth of the market are rise in prevalence of implant-associated infections and rise in prevalence of implant-associated infections drive the market growth. However, high cost of implants with antimicrobial coating hampers the market growth.

Which are the key players in the orthopedic implant antibacterial coatings surface treatment market?

Key players in the market are DOT GmbH, Covalon Technologies Ltd., Sciessent LLC, Harland Medical Systems, Inc., Isoflux, Inc., Allvivo Vascular, Inc., aap Implantate AG, BASF SE, Agienic Inc., ARAN BIOMEDICAL among others.

What are the key trends in the orthopedic implant antibacterial coatings surface treatment market?

Increasing number of product launches and strategic initiatives taken by market players is likely to act as trend the market growth in the comping years.

Which is the most influencing segment growing in the orthopedic implant antibacterial coatings surface treatment market report?

Active Surface Finishing/Modifications (ASM) segment growing in the orthopedic implant antibacterial coatings surface treatment market.

What are the opportunities for new orthopedic implant antibacterial coatings surface treatment market entrants?

High market potential in developing economies is likely to fuel the market growth in the comping years.

Which region is lucrative for the orthopedic implant antibacterial coatings surface treatment market?

Asia-Pacific is the lucrative for the orthopedic implant antibacterial coatings surface treatment market.

The List of Companies - Orthopedic Implant Antibacterial Coatings Surface Treatment Market

  1. DOT GmbH
  2. Covalon Technologies Ltd.
  3. Sciessent LLC
  4. Harland Medical Systems, Inc.
  5. Isoflux, Inc.
  6. Allvivo Vascular, Inc.
  7. aap Implantate AG
  8. BASF SE
  9. Agienic Inc.
  10. ARAN BIOMEDICAL

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Orthopedic Implant Antibacterial Coatings Surface Treatment Market